Published in Medicine (Baltimore) on February 01, 2016
A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study. PLoS One (2016) 0.77
Complement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic Arthritis. PLoS One (2016) 0.76
Prevalence of diabetes and unrecognized diabetes in hypertensive patients aged 40 to 79 years in southwest China. PLoS One (2017) 0.75
Plantar fascia enthesopathy is highly prevalent in diabetic patients without peripheral neuropathy and correlates with retinopathy and impaired kidney function. PLoS One (2017) 0.75
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. PLoS One (2017) 0.75
Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis. Sci Rep (2017) 0.75
Standards of medical care in diabetes--2014. Diabetes Care (2014) 20.97
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum (2010) 18.82
The mortality of rheumatoid arthritis. Arthritis Rheum (1994) 6.18
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis (2009) 5.82
Insulin resistance in essential hypertension. N Engl J Med (1987) 3.78
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis (2013) 3.25
Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA (2011) 3.02
The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis (2011) 2.95
The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum (2007) 2.25
Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis (2012) 2.24
Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome. Am Heart J (2013) 2.14
One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care (2008) 2.13
Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke. Stroke (2006) 1.99
Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem (2008) 1.80
Insulin resistance and body fat distribution. Diabetes Care (1996) 1.57
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis (2010) 1.55
Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis (2008) 1.50
Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reduction. Arthritis Rheum (2012) 1.48
Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum (2008) 1.45
Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia (2013) 1.36
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatology (Oxford) (2014) 1.34
Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum (2010) 1.21
Prevalence of NIDDM and impaired glucose tolerance in Italy: an OGTT-based population study. Diabetologia (1995) 1.18
Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study. Rheumatology (Oxford) (2013) 1.11
Mortality trends in patients with early rheumatoid arthritis over 20 years: results from the Norfolk Arthritis Register. Arthritis Care Res (Hoboken) (2014) 1.08
Assessing the shape of the glucose curve during an oral glucose tolerance test. Diabetes Care (2003) 1.04
Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose. Acta Diabetol (2011) 1.04
Associations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis. Ann Med (2014) 0.98
Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease. Arthritis Care Res (Hoboken) (2011) 0.98
Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther (2013) 0.95
The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoS One (2015) 0.95
Monitoring diabetes in patients with and without rheumatoid arthritis: a Medicare study. Arthritis Res Ther (2012) 0.94
Infliximab and insulin resistance. Autoimmun Rev (2010) 0.92
Impact of rheumatoid arthritis on receiving a diagnosis of hypertension among patients with regular primary care. Arthritis Care Res (Hoboken) (2014) 0.91
Diabetes mellitus risk factors in rheumatoid arthritis: a systematic review and meta-analysis. Clin Exp Rheumatol (2014) 0.91
Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor α therapy. Arthritis Care Res (Hoboken) (2012) 0.91
Seven-year mortality in heart failure patients with undiagnosed diabetes: an observational study. Cardiovasc Diabetol (2011) 0.90
Visfatin, resistin, hsCRP and insulin resistance in relation to abdominal obesity in women with rheumatoid arthritis. Clin Exp Rheumatol (2010) 0.87
Risk of rheumatoid arthritis in patients with type 2 diabetes: a nationwide population-based case-control study. PLoS One (2014) 0.84
Identification of undiagnosed diabetes and quality of diabetes care in the United States: cross-sectional study of 11.5 million primary care electronic records. CMAJ Open (2014) 0.82
Effect of hydroxychloroquine on insulin sensitivity and lipid parameters in rheumatoid arthritis patients without diabetes mellitus: a randomized, blinded crossover trial. Arthritis Care Res (Hoboken) (2014) 0.81
Brief report: accelerated aging influences cardiovascular disease risk in rheumatoid arthritis. Arthritis Rheum (2013) 0.78
Reduced kidney function in acute coronary syndrome patients with undiagnosed diabetes or pre-diabetes. Nephrology (Carlton) (2013) 0.78
Prevalence of diagnosed and undiagnosed diabetes mellitus and impaired fasting glucose in Sardinia. Acta Diabetol (2008) 0.77
Admission hyperglycemia in acute myocardial infarction: possible role in unveiling patients with previously undiagnosed diabetes mellitus. J Cardiovasc Med (Hagerstown) (2013) 0.76
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum (2005) 3.31
Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol (2011) 2.60
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol (2002) 2.46
Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int (2008) 2.38
Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis (2002) 2.25
Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int (2004) 2.19
Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol (2012) 2.18
Detection of pulmonary congestion by chest ultrasound in dialysis patients. JACC Cardiovasc Imaging (2010) 2.16
Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation (2002) 2.02
Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation (2002) 2.02
Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis. J Hepatol (2008) 2.00
Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. J Am Soc Nephrol (2005) 1.99
Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol (2009) 1.86
TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells. Arterioscler Thromb Vasc Biol (2008) 1.79
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis (2013) 1.74
Role of the forkhead protein FoxO1 in beta cell compensation to insulin resistance. J Clin Invest (2006) 1.74
ACE inhibition is renoprotective among obese patients with proteinuria. J Am Soc Nephrol (2011) 1.70
Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care (2007) 1.65
Ultrafiltration intensification in hemodialysis patients improves hypertension but increases AV fistula complications and cardiovascular events. J Nephrol (2011) 1.62
Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis. Rheumatology (Oxford) (2009) 1.60
Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: evidence for a vanishing infection. Dig Liver Dis (2012) 1.55
Phosphate attenuates the anti-proteinuric effect of very low-protein diet in CKD patients. Nephrol Dial Transplant (2012) 1.53
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study. J Rheumatol (2011) 1.52
Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes. Eur J Clin Pharmacol (2009) 1.50
Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients. Am J Kidney Dis (2005) 1.49
The functional Q84R polymorphism of mammalian Tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy. Diabetes (2005) 1.49
Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects. Diabetes (2006) 1.49
Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis. J Res Med Sci (2012) 1.47
Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients. Kidney Int (2010) 1.47
Sample size calculations: basic principles and common pitfalls. Nephrol Dial Transplant (2010) 1.47
Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists? Arthritis Care Res (Hoboken) (2012) 1.46
Urotensin II and biomarkers of endothelial activation and atherosclerosis in end-stage renal disease. Am J Hypertens (2006) 1.46
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease. J Hypertens (2003) 1.42
An unusual cause of dysphagia. J Rheumatol (2012) 1.38
The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5'-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes. J Clin Endocrinol Metab (2006) 1.36
Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? Kidney Int (2002) 1.33
Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature. Arthritis Rheum (2008) 1.30
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine. Arthritis Care Res (Hoboken) (2013) 1.29
Variant near ADAMTS9 known to associate with type 2 diabetes is related to insulin resistance in offspring of type 2 diabetes patients--EUGENE2 study. PLoS One (2009) 1.29
Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation? BMC Cancer (2002) 1.28
Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol (2004) 1.27
Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int (2002) 1.27
Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients? J Am Soc Nephrol (2006) 1.26
Ileal pouchitis-related arthritis. Semin Arthritis Rheum (2002) 1.23
Enthesitis. Best Pract Res Clin Rheumatol (2006) 1.21
Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int (2002) 1.20
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia (2011) 1.20
Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol (2006) 1.19
Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol (2002) 1.17
Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant (2006) 1.17
Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria. Diabetes Care (2012) 1.16
Norepinephrine and concentric hypertrophy in patients with end-stage renal disease. Hypertension (2002) 1.15
Adverse effects of atypical antipsychotics in the elderly: a review. Drugs Aging (2006) 1.15
The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study. Clin Rheumatol (2011) 1.15
Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Eur J Pharmacol (2003) 1.13
Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients. J Am Soc Nephrol (2002) 1.13
Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab (2004) 1.12
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy. Epilepsia (2009) 1.11
Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl (2003) 1.11
Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation (2004) 1.11
Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int Suppl (2003) 1.10
Pulmonary congestion predicts cardiac events and mortality in ESRD. J Am Soc Nephrol (2013) 1.09
The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis. Oncogene (2004) 1.08
Left ventricular systolic function monitoring in asymptomatic dialysis patients: a prospective cohort study. J Am Soc Nephrol (2006) 1.08
One-hour postload plasma glucose levels are associated with kidney dysfunction. Clin J Am Soc Nephrol (2010) 1.08
Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation. J Mol Med (Berl) (2009) 1.08
Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int (2005) 1.08
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum (2007) 1.07
Low triiodothyronine: a new facet of inflammation in end-stage renal disease. J Am Soc Nephrol (2005) 1.07
Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol (2004) 1.06
Novel potent anticonvulsant agent containing a tetrahydroisoquinoline skeleton. J Med Chem (2006) 1.06
Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease. J Hypertens (2006) 1.05
Cardiac consequences of hypertension in hemodialysis patients. Semin Dial (2004) 1.05
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. Kidney Int (2013) 1.05
Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections. Nephrol Dial Transplant (2006) 1.05
The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients. Diabetes (2011) 1.05
The HLA-B*2709 subtype in a woman with early ankylosing spondylitis. Arthritis Rheum (2007) 1.04
Expression and localization of the homeodomain-containing protein HEX in human thyroid tumors. J Clin Endocrinol Metab (2002) 1.04
The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol (2009) 1.04
C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Diabetes Care (2005) 1.04
Mast cell positivity to tryptase correlates with metastatic lymph nodes in gastrointestinal cancer patients treated surgically. Oncology (2013) 1.03
Predictors of cardiovascular death in ESRD. Semin Nephrol (2005) 1.03
Adiponectin in essential hypertension. J Nephrol (2002) 1.03
Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Phytother Res (2013) 1.03
Diffuse idiopathic skeletal hyperostosis: differentiation from ankylosing spondylitis. Curr Rheumatol Rep (2009) 1.03
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. Neuropharmacology (2012) 1.03
Prognostic value of the New York Heart Association classification in end-stage renal disease. Nephrol Dial Transplant (2007) 1.02
International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis Rheum (2009) 1.02
Effects of mutations in the insulin-like growth factor signaling system on embryonic pancreas development and beta-cell compensation to insulin resistance. J Biol Chem (2002) 1.02
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann Rheum Dis (2010) 1.02
Hepatitis C virus-related arthritis. Autoimmun Rev (2008) 1.02